CytomX Therapeutics (CTMX) Earnings Date & Reports

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CTMX is expected to report earnings to fall 17.00% to -8 cents per share on August 06

CytomX Therapeutics CTMX Stock Earnings Reports

Q2'26

Est.

$-0.08

Q1'26

Beat

by $0.02

Q4'25

Missed

by $0.08

Q3'25

Missed

by $0.04

Q2'25

Beat

by $0.06

The last earnings report on May 07 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 4.60M shares outstanding, the current market capitalization sits at 648.75M.

View a ticker or compare two or three

Compare

CTMX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CTMX